Bayesian Capital Management, LP Ligand Pharmaceuticals Inc Put Options Transaction History
Bayesian Capital Management, LP
- $600 Million
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding LGND
# of Institutions
307Shares Held
19.9MCall Options Held
9KPut Options Held
0-
Black Rock Inc. New York, NY2.87MShares$601 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.08MShares$435 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X01.06MShares$222 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3927KShares$194 Million0.13% of portfolio
-
State Street Corp Boston, MA750KShares$157 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $3.53B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...